MAPT and Alzheimer disease: As for Tau, we selected the peptide Tau1 (residues 19–34), which is in the N-terminal end of the Tau protein, since phospho-Tyr-hTau located in the N-terminal was reported to accompany AD progression and Tauopathy [13].